Press Releases

Date	Title	Company
06-Dec-2023	TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer	Businesswire
06-Dec-2023	Delix Presents Interim Data From Phase I Trial of Novel Neuroplastogen at ACNP Annual Meeting	Businesswire
06-Dec-2023	Empress Therapeutics Appoints Virginia Finnerty-Brooks Chief Business Officer	Businesswire
06-Dec-2023	Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer	Businesswire
06-Dec-2023	Ionpath Announces Executive Chair Appointment and CEO Promotion	Businesswire
06-Dec-2023	Asia-Pacific Nucleic Acid Therapeutics CDMO Market Report 2023-2033: Continued R&D for Manufacturing Innovative Nucleic Acid Therapeutics Forcing Pharmaceutical Companies to Expand their Businesses - ResearchAndMarkets.com	Businesswire
06-Dec-2023	COP28 Announcement Pushes for More Timber in Construction and More Sustainable Forestry	Businesswire
06-Dec-2023	Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Deuterated Psilocybin Analog Program	Businesswire
06-Dec-2023	Managing Service Providers including CRO (Contract Research Organisation) and CMOs Oversight to comply with ICH GCP (Good Clinical Practice) R3 Training Course - ResearchAndMarkets.com	Businesswire
06-Dec-2023	Global Peptide Therapeutics Markets, Drug Dosage, Price & Clinical Trials Insights, 2029 - ResearchAndMarkets.com	Businesswire
06-Dec-2023	Coya Therapeutics Announces $26.5 Million Private Placement	Businesswire
06-Dec-2023	Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors	Businesswire
06-Dec-2023	Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)	Businesswire
06-Dec-2023	Remedy Plan Therapeutics Expands Leadership Team and Board of Directors	AccessWire
06-Dec-2023	A Comprehensive Analysis of the Insomnia Market: Valuation, Projections, and the Complex Tapestry of Sleep Challenges	The Wire Times
06-Dec-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
06-Dec-2023	Unraveling the Ascendance of the Global Sports Medicine Market – A $12.9 Billion Journey from 2020 to 2030	The Wire Times
06-Dec-2023	Global Single Cell Genome Sequencing Market Size, Share & Trends Analysis Report 2023-2030 - ResearchAndMarkets.com	Businesswire
06-Dec-2023	Samenvatting: Nieuwe post hoc-gegevensanalyse van fase 3 toont aan dat AJOVY® (fremanezumab) migraineaanvallen vermindert bij volwassen met migraine en co-morbide obesitas	Businesswire
06-Dec-2023	Global and Regional Biologics CDMO Market Analysis Report 2023: Market to Surpass $25 Billion by 2033 - Growing Trend Toward Personalized Medicine and Emerging Gene and Cell Therapies - ResearchAndMarkets.com	Businesswire